Is Nektar Therapeutics a buy?

Nektar Therapeutics has received a consensus rating of Hold. The company’s average rating score is 2.40, and is based on 2 buy ratings, 3 hold ratings, and no sell ratings.

What does Nektar Therapeutics do?

Nektar Therapeutics is a research-based development stage biopharmaceutical company that discovers and develops innovative medicines in areas of high unmet medical need. Our R&D pipeline of new investigational drugs includes treatments for cancer and auto-immune disease.

What Nktr 214?

About Bempegaldesleukin (NKTR-214), Nektar’s Lead Immuno-oncology Candidate. Bempegaldesleukin is a CD122-preferential IL-2 pathway agonist designed to stimulate the patient’s own immune system to fight cancer.

Does Nekter add sugar?

nÉkter is fresh at its best Nékter Juice Bar has entirely transformed the juice bar experience, offering total ingredient transparency by eliminating hidden fillers, unnecessary sugars, processed ingredients, and artificial flavors from its entire menu.

What NKTR 181?

NKTR-181 is a novel, long-acting, selective mu-opioid agonist with structural properties that reduce its rate of entry across the blood-brain barrier compared with traditional mu-opioid agonists.

What is Lifileucel?

Lifileucel is an autologous, centrally manufactured tumor-infiltrating lymphocyte product. METHODS. We conducted a phase II open-label, single-arm, multicenter study in patients with advanced melanoma who had been previously treated with checkpoint inhibitor(s) and BRAF ± MEK targeted agents.

What is Bempeg?

BEMPEG is an agonist of the interleukin-2 signaling pathway that was previously reported to induce demonstrated antitumor activity among patients with metastatic melanoma in combination with nivolumab in the PIVOT-02 trial.

What is Tilsotolimod?

Tilsotolimod is a DNA-based immunomodulatory oligonucleotide and a toll-like receptor 9 (TLR9) agonist being developed by Idera Pharmaceuticals for the treatment of cancer, including colorectal cancer, pancreatic cancer, lymphoma and metastatic melanoma (MM).

What is TIL therapy?

A type of treatment in which tumor-infiltrating lymphocytes (a type of immune cell that can recognize and kill cancer cells) are removed from a patient’s tumor and grown in large numbers in a laboratory.

What is Thor 707?

THOR-707 is a precisely PEGylated version of IL-2, where the PEG chain is attached to a novel amino acid inserted at a location on IL-2 that prevents it from engaging the alpha-receptor and binding to immune receptors that cause drug toxicities (IL-2R-alpha, CD25).

What is the stock price of Nektar Therapeutics?

Nektar (NKTR) reports encouraging fourth-quarter results. The company continues to progress with its pipeline candidates. Nektar (NKTR) delivered earnings and revenue surprises of 7.25% and 28.57%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?

When is the next earnings call for Nektar?

The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term. NKTR earnings call for the period ending March 31, 2021. Nektar (NKTR) delivered earnings and revenue surprises of 5.56% and -18.18%, respectively, for the quarter ended March 2021.

What are the clinical uses of nktr-358?

NKTR-358 is currently in development for the treatment of a range of autoimmune and inflammatory disorders. These published data demonstrate that NKTR-358 has the ability to elicit sustained and preferential proliferation and activation of Tregs in vivo without corresponding increases in T effector cells.